Salomon Cuts Genzyme General to 'Outperform'

Analyst Elise Wang says the company is continuing to struggle with managing U.S. wholesaler inventory levels

Salomon Smith Barney downgraded Genzyme General (GENZ ) to outperform from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.